Skip to main content
Iranian Journal of Basic Medical Sciences logoLink to Iranian Journal of Basic Medical Sciences
. 2015 Feb;18(2):172–179.

Gestational hypothyroidism-induced changes in L-type calcium channels of rat aorta smooth muscle and their impact on the responses to vasoconstrictors

Katayoun Sedaghat 1,2, Saleh Zahediasl 1,2, Asghar Ghasemi 1,2,*
PMCID: PMC4366729  PMID: 25810892

Abstract

Objective(s):

Thyroid hormones play an essential role in fetal growth and maternal hypo-thyroidism which leads to cardiovascular deficiency in their offspring. Considering this, we intended to investigate the impact of gestational hypothyroidism on offspring vascular contractibility and possible underlying mechanisms.

Materials and Methods:

Hypothyroidism was induced in female rats by administration of 6-n-propyl-2-thiouracil in drinking water (0.02%) till delivery. The offspring aorta smooth muscle (without endothelium) contractile response to KCl (10-100 mM), KCl in the presence of nifedipine (10-4-10-1 µM), phenylephrine (10-9-10-6 M) and finally, phenylephrine and caffeine 100 mM in Ca2+-free Krebs were measured.

Results:

KCl and phenylephrine-induced contractions were considerably lower in gestational hypothyroid (GH) than euthyroid offspring. GH responded to nifedipine with less sensitivity than control. The GH and control groups produced almost equal contraction in respond to phenylephrine and caffeine in Ca2+-free Krebs.

Conclusion:

This study suggests that in hypothyroid offspring L-type Ca2+ channels are less functional, while intracellular Ca2+ handling systems are less modified by low levels of maternal thyroid hormones.

Keywords: Aorta smooth muscle, Gestational hypothyroidism, L-type calcium channel

Introduction

Physiological functioning of the body systems is highly influenced by intrauterine conditions in which the mammalian fetus develops. Suboptimal maternal environment, such as insufficient availability of nutrients, oxygen, and hormones can change the developmental regulatory planning of fetal tissue, lead to diseases, such as cardiovascular and metabolic diseases in adult life (1-3). Thyroid hormones play an essential role in fetal normal development (4, 5). T3 reduces the vascular resistance and therefore, causes relaxation especially in arteries. Cardiovascular system response to hypothyroidism is low cardiac output, pulse pressure and increased vascular resistance, while the opposite symptoms are in effect in thyroid overactivation (5-7). Furthermore, either in hyperthyroidism or hypothyroidism, the response of the vessels is changed to the vasoconstrictors and vasodilators agents (8, 9). Most studies have focused on measuring the responses to vasoconstrictors in adult models of thyroid deficiencies, while there is not much evidence available on the maternal or gestational models of these diseases on the offspring’s vascular status. In many studies, it has been demonstrated that adult models of hypothyroidism develop a defective vascular smooth muscle response to α-adrenergic agonists and KCl or barium choloride in comparison to euthyroids (10-16). However, one of the few studies that investigated the effects of prenatal hypothyroid model in rats on the density of adrenoceptors, reported a decrease in the myocardial α1-adrenergic receptor density within 15-28 days after birth, indicating the modulation of adrenergic receptor proteins by thyroid hormones during fetal development (17). More recently a study showed that an isolated aorta smooth muscle (without endothelium) of congenitally hypothyroid adult male offspring of a female rat, who received 6-Propyl-2-thiouracil (PTU) during pregnancy, demonstrated markedly less contractile response to vasoconstrictors in comparison to euthyroids (8). The contraction response to KCl and α1-adrenergic agonists in the vascular smooth muscle is produced by extracellular Ca2+ influx, activated by voltage gated calcium channels (VGCC) non-voltage dependent Ca2+ influx (15, 18), and intracellular Ca2+ release from internal stores, such as sarcoplasmic reticulum (SR) (12, 15, 18). The markedly lower responses of hypothyroids to KCl and α1-agonists compared to controls, reported in previous studies suggest some impairments in function of calcium entering/releasing at the plasma membrane (through channels) (15, 19, 20) or in the intracellular systems (15, 21), respectively. There is evidence from previous studies showing that the expression and function of the VGCCs, including L-type Ca2+ channels, are under the control of thyroid hormones, via genomic and nongenomic mechanisms (20, 22-24). In this study we used a model of gestational hypothyroidism produced by dams who consumed PTU during pregnancy. Using PTU and methimazole as agents that induce thyroid deficiency in dams are valid models of inducing hypothyroid state in offspring, which has been used in several studies related to developmental pathophysiology of thyroid hormones (8, 25-31).

This study aimed to investigate whether gestational hypothyroidism in a rat model may modulate L-type Ca2+ channels functions in later adult life, determined by developing some deficiencies in aorta smooth muscle responses to the KCl and selective α1-adrenergic agonist, phenyl-ephrine. Also, gestational thyroid hormones may induce changes in offspring intracellular Ca2+ handling machinery by stimulating aorta smooth muscle cells with the internal Ca2+ releasing vasoconstrictors, such as phenylephrine and caffeine, in a Ca2+-free environment.

Materials and Methods

Animals

Female Wistar rats, 155-250 g (inbred in the Endocrine Physiology Research Center Animal Facilities) were used for mating in this study. The animals were kept in 12 hr light/dark cycle, 22±3°C temperatures and had free access to rat chow (Pars Co., Tehran) and water. Animal handling and experiments were carried out in accordance with the local ethics committee of the Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences. Maximum efforts were made to minimize the animal’s possible discomfort and stress.

Induction of gestational hypothyroidism

Hypothyroidism was induced in pregnant rats by adding 200 mg PTU (Sigma Aldrich, Germany) to 1000 ml of drinking water, from the first day of pregnancy until delivery (8, 31, 32). While the control group only received tap water, upon delivery the drug was removed from drinking water.

Experimental groups

Male offspring were weighed on days 0, 15, 30, 45, 60 and 150 of birth. Five months-old (150 days) rats were placed into the control (n=9) and gestational hypothyroid (GH) (n=10) groups and assessed for the contractile force measurement of the aorta.

Thyroid hormone measurement

To confirm the PTU-induced hypothyroidism, blood samples were drawn from the dam and neonates on delivery day and from the abdominal aorta of adult male offspring, five-months after birth. All the samples were centrifuged (3000 g, for 10 min in 4°C) and kept at -80°C until the time of the hormonal assay. T3 and T4 were measured using enzyme linked immunosorbent assay kits (Pishtaz Teb Zaman Co., Iran). Intra- and interassay coefficients of variation were 3.7 and 4.3% for T3 and 5.3 and 5.9% for T4, respectively.

Aortic ring preparation

Adult male offspring of GH and control groups were anesthetized by IP injection of 50 mg/Kg ketamine and 10 mg/Kg xylazine (16). The thorax was cut open and a section of the thoracic aorta ring was dissected and cleaned of the connective tissue and vessels in ice cold (4°C) Krebs-Henseleit solution (composition in mmol/l: NaCl 118, KCl 4.7, KH2PO4 1.2, MgSO4 1.2, CaCl2 2.5, Glucose 10, and NaHCO3 25, (Merck, Germany)), PH pH adjusted to 7.4 and temperature to 37°C and the ring was cut into 5 mm sections in length. Endothelium was removed by gently rotating the ring around a metal wire inserted into the lumen (33). The Krebs solution inside the chamber, where the ring was hocked to an isometric sensitive force transducer (MLT0202, ADInstruments, Spain), was constantly gassed with a combination of 95% O2 and 5% CO2. Contraction force data were recorded by the sensitive force transducer coupled to the PowerLab data acquisition system (ML866 PowerLab 4/30, ADInstruments, Australia). Before the experiment began, the aorta ring was placed under 2.0 g resting tension and allowed to equilibrate for a period of 60 min, while the solution inside the chamber was renewed every 15 min. To determine the removal of the endothelium, acetylcholine (10-5 M) was added to pre-contracted aorta ring with phenylephrine (10-6 M). The ability of the tissue to relax in response to acetylcholine indicated the presence of endothelium (33, 34).

Isolated aorta contraction experiments

Range of KCl (10-100 mM) and phenylephrine (10-9-10-6 M) concentrations, separated by refreshing Krebs solution and single concentrations of nifedipine (10-4- 10- µM) prior to KCl (10-100 mM) were applied to the ring tissue inside the chamber. In the second set of experiments, the Krebs solution was replaced by Ca2+-free Krebs (CaCl2 was replaced by MgCl2 1.2 mmol/l). The range of phenylephrine concentrations (10-9-10-6 M) was used to test the contractile force in Ca2+-free environment. Finally, after washing with Ca2+-free Krebs solution, caffeine 100 mM was added and the contractile force was recorded for 30min in response to that. Nifedipine was dissolved in ethyl-alcohol (96%) with the stock concentration of (3×10-3M). Caffeine (100 mM) was dissolved, while heating and stirring, in Ca2+-free Krebs (50 ml). Before applying the solution temperature was decreased to 37°C.

At the end of experiments the length and weight of the aorta ring were measured for calculating the tension produced by each of vasoconstrictor agents in the experiment normalized to cross-sectional area with the average tension displayed as g/mm2, using the formula below (8):

Cross-sectional area (mm2) = weight (mg) / length (mm) × density (for the vascular smooth muscle is 1.05 mg/mm3)

Statistical analysis

Values were presented as mean±SEM. Unpaired Student t-test was performed to analyze the differences between the tensions produced in hypothyroid vs control group. Paired Student t-test compared the differences between the data obtained from groups before and after nifedipine administration and data related to contractions recorded with Ca2+-containing and Ca2+-free Krebs solutions. Statistical analysis and graph plotting was performed by GraphPad Prism version 4.00 for Window’s (GraphPad software, San Diego, California, USA).

Results

Weight differences

Male offspring weights in the GH and control groups were significantly different on days 15 (P-value<0.01), 30, 45 and 60 (P-value<0.001) after birth (Table 1).

Table 1.

Comparing the weights of male offspring in gestational hypothyroid and control groups in 0-150 days after birth

Post-natal days GH weight (g) Control weight (g) P-value
0 6.656 ± 0.579 7.957 ± 0.425 0.1026
15 18.48 ± 1.297 24.65 ± 1.176 0.0054***
30 47.44 ± 3.761 66.26 ± 2.416 0.0002***
45 99.00 ± 9.771 128.2 ± 3.690 0.0016***
60 139.1 ± 9.525 175.6 ± 5.674 0.0021***
150 296.87 ± 3.567 311.33 ± 2.341 0.4866

Values are mean±SEM. *** P-values <0.001vs compared with control. Number of animals per group is 15; GH: Gestational hypothyroidism

Thyroid hormone measurement

serum levels of thyroid hormones, T3 and T4, in dams and neonate and adult offspring indicated a significant decrease in dams who had consumed PTU during pregnancy and GH neonates in comparison to their control groups (P-value<0.001). No differences were observed in GH adult offspring compared to controls (Table 2).

Table 2.

Levels of thyroid hormones (ng/dl) in dam, neonate (at birth) and adult offspring (at 5 months age)

Dam Offspring
Hormones Neonate Adult
Control PTU consumed Control GH Control GH
3,5,3´-Triiodothyronine (ng/dl) 93.4 ± 3.8 51.7 ± 4.9*** 62.9 ± 3.4 39.5 ± 4.3*** 95.7 ± 4.3 87.7 ± 5.3
Thyroxine (ng/dl) 2400 ± 0.2 520 ± 0.04*** 730 ± 0.06 370 ± 0.04*** 3800 ± 0.1 3400 ± 0.2

Thyroid hormones, 3,5,3´triiodothyronine (T3) and thyroxine (T4) (ng/dL) in dam and neonate and adult (5 months old) offspring. Values are mean±SEM (*** P-value<0.0001) compared with control; GH: Gestational hypothyroidism

Aortic smooth muscle contraction in response to vasoconstrictors

KCl-induced contraction

KCl concentrations (10-100 mM) were used to produce a dose-response curve. In the GH group the amplitude of contractile responses to KCl at 60, 80, and 100 mM were significantly lower than controls (for 60 and 80 mM, P-value<0.01 and for 100 mM KCl, P-value<0.001). Average maximum tension was Group compared to control (0.717±0.06 for GH vs 0.981±0.02 for control. Mean±SEM, P-value <0.001) (Figure 1a).

Figure 1a.

Figure 1a

Contraction-response graph showing the response of gestational hypothyroid (GH) and control groups to KCl. (**) P-value<0.01 and (***) P-value <0.001

Effect of Nifedipine on KCl-induced contraction

To investigate the effect of thyroid hormones on Ca2+ conductance through the membrane channels, nifedipine was used within the range of 10-10-10-7M, as separate doses against KCl (10-100 mM). Nifedipine, in a concentration dependent manner, reduced the contractile force of aorta smooth muscle in both GH and control groups (Figure 1b-e).

Figures 1.

Figures 1

Contraction-response graph shows the responses of gestational hypothyroid (GH) and control groups to KCl after adding (b) nifedipine (10-10 M), (c) nifedipine (10-9 M), (d) nifedipine (10-8 M) and (e) nifedipine (10-7 M). (f) Comparing the responses of both groups to KCl in presence of different concentrations of nifedipine (0-10-7 M). (**) P-value<0.01; indicates difference between control and GH. (+++) P-value<0.001; indicates difference between different concentrations of nifedipine in GH. (X, XXX) P-value<0.05, P-value <0.001, respectively; indicates difference between different concentrations of nifedipine in control

Generally, in control group, nifedipine with concentrations 10-9 M (P-value<0.05) and 10-8-10-7 M (P-value<0.001) inhibited the response to KCl 100mM. In GH group, nifedipine with concentrations 10-8-10-7 M, inhibited the response to KCl 100 mM (P -value<0.001) (Figure 1f).

Phenylephrine-induced contraction

Phenylephrine (10-9-10-6M)-induced contractions were used to produce a dose-response curve. GH responses to phenylephrine (10-7, 10-6M) were noticeably lower than control (P-value<0.05 and P-value<0.01, respectively) (Figure 2a). However, in Ca2+-free Krebs solution, the contractile responses of both groups to phenylephrine were almost the same (Figure 2b). The responses of aorta smooth muscle to phenylephrine was significantly reduced, when shifting from the Ca2+-containing to Ca2+-free Krebs solutions (P-value<0.001). However, responses were the same for the control and GH groups in Ca2+-free Krebs (Figure 2c).

Figures 2.

Figures 2

Average contractile force of gestational hypothyroid gestational hypothyroid (GH) groups control in response to phenylephrine (10-9-10-6M) in (a) Ca2+-containing (b) Ca2+-free Krebs solutions. (c) Differences in contraction between the two groups regarding the Ca2+ content of Krebs solution. (**P-value<0.01) indicates the difference between the GH and control groups, (+++P-value<0.001) between GH responses in normal and Ca2+-free Krebs and (XXXP-value<0.001) between control responses in normal and Ca2+-free Krebs

Caffeine-induced contraction

Caffeine (100 mM) was added in a Ca2+-free Krebs environment. Recording contraction from the aorta smooth muscle of control and GH groups for 30 min revealed no specific difference in contractile force between the two groups (0.317 ± 0.04, 0.271 ± 0.05; mean±SEM for control and GH groups, respectively; P-value=0.514)(Figure 3).

Figure 3.

Figure 3

Average tension produced by control and gestational hypothyroid (GH) groups in response to caffeine 100mM in Ca2+-free Krebs solution (P-value=0.514); GH: Gestational hypothyroidism

Discussion

In this study we tried to determine the role of thyroid hormones in developing functional calcium handling system in vasculature during fetal development to produce suitable physiological responses in adulthood. The aortic rings from the offspring of PTU consumed dams with denuded endothelial layer were prepared and their responses to vasoconstrictors were examined against those from euthyroid mothers. Our results from the initial GH and control groups responses to KCl and selective α(1-adrenoceptor agonist, phenylephrine, were almost similar to those reported in previous studies of hypothyroid adult rats who received anti-thyroid agent or thyroidectomy against euthyroids (14, 16, 35, 36). In all the studies, the hypothyroid group (preparations with denuded endothelium) reaction to KCl and α1-adrenoceptor agonists was markedly reduced in comparison to euthyroids (8, 14, 35). In our study, the marked lower responses of GH to KCl and phenylephrine, relative to controls, suggests some defects in the functioning of Ca2+ entering through Ca2+ channels or release from intracellular resources.

In an attempt to determine the possible sites of Ca2+ handling dysfunction in the GH aorta smooth muscle cells, we first used nifedipine, as a VGCC (L-type Ca2+ channel) blocker. Before nifedipine administration, the response of the control group to KCl 100mM was markedly higher than the GH response. Adding increasing concentrations of nifedipine made the contractile force induced by KCl in control group closer to GH, until both groups reached to almost equal contractile forces at the nifedipine dose of 10-7M. The stronger response to KCl and nifedipine inhibitory effect in euthyroids compared to GH suggest some displacement or dysfunction in the plasma membrane L-type Ca2+ channels of the latter group, which may possibly be related to the reduced thyroid hormone levels in fetal life. Many previous studies have shown that the expression and function of the VGCCs are controlled by thyroid hormones, via genomic and nongenomic mechanisms (20, 22-24). Investigating the effect of T3 on the slow Ca2+ channel function in cultured chick ventricular cells demonstrated an increase in slow channel Ca2+ influx and Ca2+ channel antagonist binding sites under the influence of T3 in comparison to cells grown in environment without T3 (22). There are some other reports indicating the increase in the Ca2+ currents by VGCC in aortic ring tissues (12) and rat ventricular cells along with reduction in expression of α1c-subunit of VGCC (genomic regulation) (20), or increase in L-type Ca2+ channel current and mRNA expression in hyperthryroid rabbit myocytes (24), while not affecting the Ca2+ release from SR in all of them. In contrast to previous reports, another study conducted on rat cardiac and vascular tissue demonstrated a decrease in the Ca2+ channel density in the hyperthyroid versus hypothyroid rat model (23). Most of the previous results related to the smooth muscle of cardiac vessels indicated that increase in thyroid hormones above the physiological levels would increase influx through the L-type Ca2+ channels, possibly by increasing the number of protein channels or the Ca2+ current; our data revealed the same event, through a reverse mechanism. Gestational hypothyroidism caused markedly weaker KCl-induced contractile force compared to euthyroid offspring and lower response to KCl in the presence of maximum concentration of nifedipine, indicating that it is likely a scarcity of thyroid hormones during fetal life causing the reverse mechanistic profile to hyperthyroidism, most likely through the genomic regulatory mechanism, affecting the Ca2+ channel number or conductivity.

High concentrations of selective α1-agonist, phenylephrine (10-7-10-6 M), produced significantly weaker contractions in the GH compared to control. This was similar to previous results obtained from comparable data of hypothyroid vs euthyroid adult rats that received α-agonist agents (14, 16, 35, 36). In our study, while the contraction responses to higher concentrations of phenylephrine were considerably higher for controls compared to GH, both groups’ responses significantly reduced in Ca2+ -free Krebs solution and became almost equal.

Experimentally, the activation of a1-adrenoceptors produces an increase in the intracellular [Ca2+], via two routes; opening the plasma membrane Ca2+ channels and releasing Ca2+ from internal sources. Plasma membrane Ca2+ channels are either VGCCs or non-voltage dependent Ca2+ channels, including; receptor-operated calcium channels (ROCCs), such as G-protein-coupled receptors GPCRs, like, α1-adrenoceptor-operated calcium channels and store-operated channels (SOCs) (34, 36, 37) (both are usually blocked by Ni2+) (15, 19). It has been shown that aorta smooth muscle contraction induced by α1-adrenoceptors is highly dependent on Ca2+ entry from extracellular environment. A study showed that nimodipine, strongly inhibit contraction force produced by noradrenaline, almost similar to the inhibitory effect of prazocine on aorta smooth muscle contraction (15), implying the joint effect of α1-adrenoceptor to voltage and non-voltage dependent Ca2+ channels for replenishing intracellular [Ca2+] and producing contraction.

In the scarcity of extracellular Ca2+, an α1-agonist, such as phenylephrine depletes the internal Ca2+ sources, which the contractile force would be entirely dependent on. In our study, while there was a significant difference in control and GH responses to phenylephrine in the presence of ample extracellular Ca2+, their responses to the same stimulant became similar in Ca2+-free Krebs. The change in the responses relative to the presence and the absence of extracellular [Ca2+], suggests that low thyroid hormone levels during fetal life does not modify the intracellular Ca2+ releasing systems in GH, while strongly affects gene expression, protein structure or function of L-type Ca2+ channels. Therefore, while GH aorta cells are still dependent on normal extracellular [Ca2+] to produce contraction in response to α1-adrenergic agonist vasoconstrictors, they are less sensitive (35, 36) in their responses to them in comparison to euthyroids. Furthermore, in Ca2+-free Krebs, the caffeine-induced contraction force was almost the same for both groups. In Ca2+-free environment, caffeine acts on ryanodine receptors to release Ca2+ from internal sources (11, 15, 38), a result which likely supports those mentioned above in the way that internal Ca2+ -releasing machinery is least changed by low thyroid hormones during fetal life.

Another point to consider in this study was the normal levels of thyroid hormones (T3 and T4) in the GH adult rats compared to controls. Therefore, the differences in the contractile responses observed between adult GH and euthyroids may have been stemmed from genetic modifications in the structure and function of the Ca2+ channels. These modifications are initiated in the prenatal or early postnatal periods of life and developed in adulthood, during which thyroid hormones began to reach to their normal physiological levels.

This study provides new insights towards deeper understanding of the changes in the vascular reactions in gestational hypothyroidism, by emphasizing on the role of modified calcium channels in producing contractions. However, it still lacks the mechanistic view of the underlying reasons, which can be gained through precise measurements of changes at the genes or/and protein levels of the Ca2+ channels, which warrants to be considered in the future.

Conclusion

The contractile responses to vasoconstrictors in adult hypothyroid rats as well as fetal or GHs are considerably reduced in comparison to euthyroids. Our results suggest that lower levels of thyroid hormones during pregnancy affects Ca2+ handling system by reducing the Ca2+ conductance through plasma membrane with least modification in internal Ca2+ releasing/storing systems. Obtained results which may have some valuable clinical relevance in the future on treatment options for cardiovascular problems of offspring born to hypothyroid mothers.

Acknowledgment

This study was supported by a grant (No. 497) from Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Authors would like to thanks from Mahyar Baveisi and Fatemeh Bagheripuor for their technical helps.

Footnotes

Conflict of interest The authors declare that they have no conflict of interest related to this manuscript.

References

  • 1.Bertram CE. Animal models and programming of the metabolic syndrome. Br Med Bull. 2001;60:103–121. doi: 10.1093/bmb/60.1.103. [DOI] [PubMed] [Google Scholar]
  • 2.Fowden AL, Forhead AJ. Endocrine mechanisms of intrauterine programming. Reproduction. 2004;127:515–26. doi: 10.1530/rep.1.00033. [DOI] [PubMed] [Google Scholar]
  • 3.Fowden AL, Giussani DA, Forhead AJ. Intrauterine programming of physiological systems: Causes and consequences. Physiology. 2006;21:29–37. doi: 10.1152/physiol.00050.2005. [DOI] [PubMed] [Google Scholar]
  • 4.Zahediasl S. Importance of thyroid hormones in intrauterine programming. Int J Endocrinol Metab. 2010;8:186–7. [Google Scholar]
  • 5.Patel J, Landers K, Li H, Mortimer RH, Richard K. Delivery of maternal thyroid hormones to the fetus. Trends Endocrinol Metab. 2011;22:164–70. doi: 10.1016/j.tem.2011.02.002. [DOI] [PubMed] [Google Scholar]
  • 6.Danzi S, Klein I. Thyroid hormone and the cardiovascular system. Med Clin North Am. 2012;96:257–68. doi: 10.1016/j.mcna.2012.01.006. [DOI] [PubMed] [Google Scholar]
  • 7.van Tuyl M, Blommaart PE, de Boer PA, Wert SE, Ruijter JM, Islam S, et al. Prenatal exposure to thyroid hormone is necessary for normal postnatal development of murine heart and lungs. Dev Biol. 2004;272:104–17. doi: 10.1016/j.ydbio.2004.03.042. [DOI] [PubMed] [Google Scholar]
  • 8.Khaksari M, Shafiee M, Ghasemi A, Asl SZ. Effect of orally administered propylthiouracil in pregnant and lactating rats on isolated aorta contractility of their adult male offspring. Med Sci Monit. 2009;15:BR123–7. [PubMed] [Google Scholar]
  • 9.Sutandar M, Garcia-Bournissen F, Koren G. Hypothyroidism in pregnancy. J Obstet Gynaecol Can. 2007;29:354–6. doi: 10.1016/S1701-2163(16)32437-9. [DOI] [PubMed] [Google Scholar]
  • 10.Sabio JM, Rodriguez-Maresca M, Luna JD, Garcia del Rio C, Vargas F. Vascular reactivity to vasoconstrictors in aorta and renal vasculature of hyperthyroid and hypothyroid rats. Pharmacology. 1994;49:257–64. doi: 10.1159/000139241. [DOI] [PubMed] [Google Scholar]
  • 11.Sanders KM. Invited review: mechanisms of calcium handling in smooth muscles. J Appl Physiol. 2001;91:1438–49. doi: 10.1152/jappl.2001.91.3.1438. [DOI] [PubMed] [Google Scholar]
  • 12.Stratton DB, Morrow RJ. Calcium mobilization and sensitivity in intact and triton skinned aorta from thyropathologic rats. Life Sci. 1991;48:2207–14. doi: 10.1016/0024-3205(91)90334-8. [DOI] [PubMed] [Google Scholar]
  • 13.Rahmani MA, Cheema IR, Sen S, Peoples B, Riley SR. The effect of hyperthyroidism and hypothyroidism on alpha 1- and alpha 2-adrenergic responsiveness in rat aortic smooth muscle. Artery. 1987;14:362–83. [PubMed] [Google Scholar]
  • 14.Pantos C, Mourouzis C, Katramadou M, Saranteas T, Mourouzis I, Karageorgiou H, et al. Decreased vascular reactivity to alpha1 adrenergic stimulation in the presence of hypothyroid state: a part of an adaptive response? Int Angiol. 2006;25:216–20. [PubMed] [Google Scholar]
  • 15.Gisbert R, Perez-Vizcaino F, Cogolludo AL, Noguera MA, Ivorra MD, Tamargo J, et al. Cytosolic Ca2+and phosphoinositide hydrolysis linked to constitutively active alpha 1D-adrenoceptors in vascular smooth muscle. J Pharmacol Exp Ther. 2003;305:1006–14. doi: 10.1124/jpet.102.046169. [DOI] [PubMed] [Google Scholar]
  • 16.Brown L, Nankervis R, Kerr D, Sernia C. Adrenoceptor-mediated cardiac and vascular responses in hypothyroid rats. Biochem Pharmacol. 1994;47:281–8. doi: 10.1016/0006-2952(94)90018-3. [DOI] [PubMed] [Google Scholar]
  • 17.Noguchi A, Whitsett JA. Ontogeny of alpha 1-adrenergic receptors in the rat myocardium: effects of hypothyroidism. Eur J Pharmacol. 1982;86:43–50. doi: 10.1016/0014-2999(82)90394-6. [DOI] [PubMed] [Google Scholar]
  • 18.Zhong H, Minneman KP. Alpha1-adrenoceptor subtypes. Eur J Pharmacol. 1999;375:261–76. doi: 10.1016/s0014-2999(99)00222-8. [DOI] [PubMed] [Google Scholar]
  • 19.Guibert C, Ducret T, Savineau JP. Voltage-independent calcium influx in smooth muscle. Prog Biophys Mol Biol. 2008;98:10–23. doi: 10.1016/j.pbiomolbio.2008.05.001. [DOI] [PubMed] [Google Scholar]
  • 20.Watanabe H, Washizuka T, Komura S, Yoshida T, Hosaka Y, Hatada K, et al. Genomic and non-genomic regulation of L-type calcium channels in rat ventricle by thyroid hormone. Endocr Res. 2005;31:59–70. doi: 10.1080/07435800500229227. [DOI] [PubMed] [Google Scholar]
  • 21.Vetter R, Rehfeld U, Reissfelder C, Fechner H, Seppet E, Kreutz R. Decreased cardiac SERCA2 expression, SR Ca uptake, and contractile function in hypothyroidism are attenuated in SERCA2 overexpressing transgenic rats. Am J Physiol Heart Circ Physiol. 2011;300:H943–50. doi: 10.1152/ajpheart.00490.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Kim D. Effect of Thyroid Hormone on slow Calcium channel function in cultured chick ventricular cells. J Clin Invest. 1987;80:88–94. doi: 10.1172/JCI113068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Hawthron MH. Effect of thyroid status on beta-adrenoceptors and calcium channels in rat cardiac and vascular tissue. Naunyn Schmiedebergs Arch Pharmacol. 1988;337:539–544. doi: 10.1007/BF00182728. [DOI] [PubMed] [Google Scholar]
  • 24.Yu Z, Wang T, Xu L, Huang CX. Thyroid hormone increased L-type calcium channel mRNA expression and L-type calcium current of myocytes in rabbits. Biomed Mater Eng. 2012;22:49–55. doi: 10.3233/BME-2012-0689. [DOI] [PubMed] [Google Scholar]
  • 25.Narayanan CH, Narayanan Y, Browne RC. Effects of induced thyroid deficiency on the development of suckling behavior in rats. Physiol Behav. 1982;29:361–70. doi: 10.1016/0031-9384(82)90027-0. [DOI] [PubMed] [Google Scholar]
  • 26.Koromilas C, Liapi C, Zarros A, Stolakis V, Tsagianni A, Skandali N, et al. Effects of experimentally-induced maternal hypothyroidism on crucial offspring rat brain enzyme activities. Int J Dev Neurosci. 2014;35C:1–6. doi: 10.1016/j.ijdevneu.2014.03.002. [DOI] [PubMed] [Google Scholar]
  • 27.Goodman JH, Gilbert ME. Modest thyroid hormone insufficiency during development induces a cellular malformation in the corpus callosum: a model of cortical dysplasia. Endocrinology. 2007;148:2593–7. doi: 10.1210/en.2006-1276. [DOI] [PubMed] [Google Scholar]
  • 28.Gilbert ME, Sui L, Walker MJ, Anderson W, Thomas S, Smoller SN, et al. Thyroid hormone insufficiency during brain development reduces parvalbumin immunoreactivity and inhibitory function in the hippocampus. Endocrinology. 2007;148:92–102. doi: 10.1210/en.2006-0164. [DOI] [PubMed] [Google Scholar]
  • 29.Ahmed OM, Abd El-Tawab SM, Ahmed RG. Effects of experimentally induced maternal hypothyroidism and hyperthyroidism on the development of rat offspring: I. The development of the thyroid hormones-neurotransmitters and adenosinergic system interactions. Int J Dev Neurosci. 2010;28:437–54. doi: 10.1016/j.ijdevneu.2010.06.007. [DOI] [PubMed] [Google Scholar]
  • 30.Amerion M, Tahajjodi S, Hushmand Z, Mahdavi Shahri N, Nikravesh MR, Jalali M. The effect of maternal thyroid disorders (hypothyroidism and hyperthyroidism) during pregnancy and lactation on skin development in wistar rat newborns. Iran J Basic Med Sci. 2013;16:665–74. [PMC free article] [PubMed] [Google Scholar]
  • 31.Karbalaei N, Ghasemi A, Hedayati M, Godini A, Zahediasl S. The possible mechanisms by which maternal hypothyroidism impairs insulin secretion in adult male offspring in rats. Exp Physiol. 2014;99:701–14. doi: 10.1113/expphysiol.2013.073825. [DOI] [PubMed] [Google Scholar]
  • 32.Ghasemi A, Mehrazin F, Zahediasl S. Effect of nitrate and L-arginine therapy on nitric oxide levels in serum, heart, and aorta of fetal hypothyroid rats. J Physiol Biochem. 2013;69:751–9. doi: 10.1007/s13105-013-0251-x. [DOI] [PubMed] [Google Scholar]
  • 33.Weber LP, Chow WL, Abebe W, MacLeod KM. Enhanced contractile responses of arteries from streptozotocin diabetic rats to sodium fluoride. Br J Pharmacol. 1996;118:115–22. doi: 10.1111/j.1476-5381.1996.tb15373.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.McAllister RM, Grossenburg VD, Delp MD, Laughlin MH. Effects of hyperthyroidism on vascular contractile and relaxation responses. Am J Physiol. 1998;274:E946–53. doi: 10.1152/ajpendo.1998.274.5.E946. [DOI] [PubMed] [Google Scholar]
  • 35.Gunasekera RD, Kuriyama H. The influence of thyroid states upon responses of the rat aorta to catecholamines. Br J Pharmacol. 1990;99:541–7. doi: 10.1111/j.1476-5381.1990.tb12965.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Vargas F, Moreno JM, Rodriguez-Gomez I, Wangensteen R, Osuna A, Alvarez-Guerra M, et al. Vascular and renal function in experimental thyroid disorders. Eur J Endocrinol. 2006;154:197–212. doi: 10.1530/eje.1.02093. [DOI] [PubMed] [Google Scholar]
  • 37.McFadzean I, Gibson A. The developing relationship between receptor-operated and store-operated calcium channels in smooth muscle. Br J Pharmacol. 2002;135:1–13. doi: 10.1038/sj.bjp.0704468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Karaki H, Ozaki H, Hori M, Mitsui-Saito M, Amano K, Harada K, et al. Calcium movements, distribution, and functions in smooth muscle. Pharmacol Rev. 1997;49:157–230. [PubMed] [Google Scholar]

Articles from Iranian Journal of Basic Medical Sciences are provided here courtesy of Mashhad University of Medical Sciences

RESOURCES